| Shipley & Sills Family Practice, Pllc | |
|
4003 Massard Rd. Fort Smith AR 72903 | |
| (479) 226-3836 | |
| (479) 434-5987 |
| Full Name | Shipley & Sills Family Practice, Pllc |
|---|---|
| Speciality | Family Medicine |
| Location | 4003 Massard Rd., Fort Smith, Arkansas |
| Authorized Official Name and Position | Melissa Pulliam (BUSINESS MANAGER) |
| Authorized Official Contact | 4792263836 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Shipley & Sills Family Practice, Pllc 4003 Massard Rd Fort Smith AR 72903 Ph: (479) 226-3836 | Shipley & Sills Family Practice, Pllc 4003 Massard Rd. Fort Smith AR 72903 Ph: (479) 226-3836 |
| NPI Number | 1104105972 |
|---|---|
| Provider Enumeration Date | 08/11/2011 |
| Last Update Date | 07/28/2014 |
| Medicare PECOS PAC ID | 3870751969 |
|---|---|
| Medicare Enrollment ID | O20120221000432 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Imagine if scientists could stop the coronavirus infection in its tracks simply by diverting its attention away from living lung cells? A new therapeutic countermeasure, announced in a Nano Letters study by researchers from Boston University's National Emerging Infectious Diseases Laboratories and the University of California San Diego, appears to do just that in experiments that were carried out at the NEIDL in Boston.
New hope for deadly pediatric brain tumors; opening the door to improved diagnosis and treatment of epilepsy in children; and advanced genetic testing to better understand the causes of autism and cancer in kids. These research projects are currently underway at Mattel Children's Hospital UCLA under the umbrella of the UCLA Children's Discovery and Innovation Institute (CDI), and aim to dramatically improve the lives of children with serious illnesses.
Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, is pleased to announce that it has been selected as a winner of the annual New York Venture Summit Top Innovator award by youngStartup Ventures. The companies awarded this honor have been identified as those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104105972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | (* (Not Available)) | Primary |
| Provider Name | David Barton Sills |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1063409878 PECOS PAC ID: 7012826498 Enrollment ID: I20040211001239 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Imagine if scientists could stop the coronavirus infection in its tracks simply by diverting its attention away from living lung cells? A new therapeutic countermeasure, announced in a Nano Letters study by researchers from Boston University's National Emerging Infectious Diseases Laboratories and the University of California San Diego, appears to do just that in experiments that were carried out at the NEIDL in Boston.
New hope for deadly pediatric brain tumors; opening the door to improved diagnosis and treatment of epilepsy in children; and advanced genetic testing to better understand the causes of autism and cancer in kids. These research projects are currently underway at Mattel Children's Hospital UCLA under the umbrella of the UCLA Children's Discovery and Innovation Institute (CDI), and aim to dramatically improve the lives of children with serious illnesses.
Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, is pleased to announce that it has been selected as a winner of the annual New York Venture Summit Top Innovator award by youngStartup Ventures. The companies awarded this honor have been identified as those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
› Verified 5 days ago
| Provider Name | Wendy A Gaston |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548204654 PECOS PAC ID: 3072564806 Enrollment ID: I20050312000051 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Imagine if scientists could stop the coronavirus infection in its tracks simply by diverting its attention away from living lung cells? A new therapeutic countermeasure, announced in a Nano Letters study by researchers from Boston University's National Emerging Infectious Diseases Laboratories and the University of California San Diego, appears to do just that in experiments that were carried out at the NEIDL in Boston.
New hope for deadly pediatric brain tumors; opening the door to improved diagnosis and treatment of epilepsy in children; and advanced genetic testing to better understand the causes of autism and cancer in kids. These research projects are currently underway at Mattel Children's Hospital UCLA under the umbrella of the UCLA Children's Discovery and Innovation Institute (CDI), and aim to dramatically improve the lives of children with serious illnesses.
Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, is pleased to announce that it has been selected as a winner of the annual New York Venture Summit Top Innovator award by youngStartup Ventures. The companies awarded this honor have been identified as those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
› Verified 5 days ago
| Provider Name | Donna M. Shipley |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1205970209 PECOS PAC ID: 3577637560 Enrollment ID: I20080808000779 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Imagine if scientists could stop the coronavirus infection in its tracks simply by diverting its attention away from living lung cells? A new therapeutic countermeasure, announced in a Nano Letters study by researchers from Boston University's National Emerging Infectious Diseases Laboratories and the University of California San Diego, appears to do just that in experiments that were carried out at the NEIDL in Boston.
New hope for deadly pediatric brain tumors; opening the door to improved diagnosis and treatment of epilepsy in children; and advanced genetic testing to better understand the causes of autism and cancer in kids. These research projects are currently underway at Mattel Children's Hospital UCLA under the umbrella of the UCLA Children's Discovery and Innovation Institute (CDI), and aim to dramatically improve the lives of children with serious illnesses.
Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, is pleased to announce that it has been selected as a winner of the annual New York Venture Summit Top Innovator award by youngStartup Ventures. The companies awarded this honor have been identified as those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
› Verified 5 days ago
| Provider Name | Sunny Deshai Bray |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437517281 PECOS PAC ID: 9739484718 Enrollment ID: I20160301000064 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Imagine if scientists could stop the coronavirus infection in its tracks simply by diverting its attention away from living lung cells? A new therapeutic countermeasure, announced in a Nano Letters study by researchers from Boston University's National Emerging Infectious Diseases Laboratories and the University of California San Diego, appears to do just that in experiments that were carried out at the NEIDL in Boston.
New hope for deadly pediatric brain tumors; opening the door to improved diagnosis and treatment of epilepsy in children; and advanced genetic testing to better understand the causes of autism and cancer in kids. These research projects are currently underway at Mattel Children's Hospital UCLA under the umbrella of the UCLA Children's Discovery and Innovation Institute (CDI), and aim to dramatically improve the lives of children with serious illnesses.
Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, is pleased to announce that it has been selected as a winner of the annual New York Venture Summit Top Innovator award by youngStartup Ventures. The companies awarded this honor have been identified as those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
› Verified 5 days ago
| Provider Name | Janice Darlene Sudbrink |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295192847 PECOS PAC ID: 9537465471 Enrollment ID: I20160302002579 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Imagine if scientists could stop the coronavirus infection in its tracks simply by diverting its attention away from living lung cells? A new therapeutic countermeasure, announced in a Nano Letters study by researchers from Boston University's National Emerging Infectious Diseases Laboratories and the University of California San Diego, appears to do just that in experiments that were carried out at the NEIDL in Boston.
New hope for deadly pediatric brain tumors; opening the door to improved diagnosis and treatment of epilepsy in children; and advanced genetic testing to better understand the causes of autism and cancer in kids. These research projects are currently underway at Mattel Children's Hospital UCLA under the umbrella of the UCLA Children's Discovery and Innovation Institute (CDI), and aim to dramatically improve the lives of children with serious illnesses.
Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, is pleased to announce that it has been selected as a winner of the annual New York Venture Summit Top Innovator award by youngStartup Ventures. The companies awarded this honor have been identified as those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
› Verified 5 days ago
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Imagine if scientists could stop the coronavirus infection in its tracks simply by diverting its attention away from living lung cells? A new therapeutic countermeasure, announced in a Nano Letters study by researchers from Boston University's National Emerging Infectious Diseases Laboratories and the University of California San Diego, appears to do just that in experiments that were carried out at the NEIDL in Boston.
New hope for deadly pediatric brain tumors; opening the door to improved diagnosis and treatment of epilepsy in children; and advanced genetic testing to better understand the causes of autism and cancer in kids. These research projects are currently underway at Mattel Children's Hospital UCLA under the umbrella of the UCLA Children's Discovery and Innovation Institute (CDI), and aim to dramatically improve the lives of children with serious illnesses.
Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, is pleased to announce that it has been selected as a winner of the annual New York Venture Summit Top Innovator award by youngStartup Ventures. The companies awarded this honor have been identified as those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
› Verified 5 days ago
Healthmax Center Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12300 Highway 71 S, Suite A, Fort Smith, AR 72916 Phone: 479-755-6595 Fax: 479-755-6596 | |
Waldron Place Pediatric Clinic, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1501 S Waldron Rd Ste 202, Fort Smith, AR 72903 Phone: 479-452-8311 Fax: 479-452-5032 | |
Rvpcs Northside Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4900 Kelley Highway, Fort Smith, AR 72904 Phone: 479-785-5700 Fax: 479-785-5708 | |
Fort Smith Eye Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8301 Rogers Ave, Doctor's Office, Fort Smith, AR 72903 Phone: 479-452-1580 Fax: 479-452-6910 | |
Premise Health - Rheem Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5600 Old Greenwood Rd, Fort Smith, AR 72908 Phone: 479-242-4290 Fax: 479-242-4640 | |
Remedy Health Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1501 S Waldron Rd Ste 100, Fort Smith, AR 72903 Phone: 479-888-8305 Fax: 918-395-9149 | |
Available Medical Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7320 Rogers Ave, Suite 1, Fort Smith, AR 72903 Phone: 479-452-6362 Fax: 479-484-5652 |